Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Testagen Dosage, Reconstitution & Mixing Trends | World Peptide Association

Testagen Dosage, Reconstitution & Mixing Trends See Testagen dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions. Testagen is a Khavinson-family tetrapeptide (Lys-Glu-Asp-Gly) targeting testicular tissu

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Testagen Dosage, Reconstitution & Mixing Trends

See Testagen dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.

Testagen is a Khavinson-family tetrapeptide (Lys-Glu-Asp-Gly) targeting testicular tissue and Leydig cell function, with reported preclinical effects on testosterone biosynthesis in aged rodent models. It sits in the same St. Petersburg Institute of Bioregulation framework as the broader Khavinson short-peptide family. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when reconstituting Testagen.

20 Testagen reconstitution calculations have been logged by the WPA community. The most common dose entered is 100mcg (4 calculations). The median dose across all sessions is 2mg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 20mg (19 sessions). The most common dosing frequency is daily (7x/week) (3 logged protocols).

World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.

All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Testagen Dosage Chart

Testagen is dosed at 100 mcg–300 mcg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only. Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration. Typical daily range: 100–300 mcg once daily (gradual titration). Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe. Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Testagen is a synthetic tetrapeptide with the sequence Lys‑Glu‑Asp‑Gly (KEDG), an anterior pituitary‑derived bioregulator studied for its role in modulating endocrine function, particularly the pituitary–gonadal axis[1][2]. Preclinical research indicates effects on thyroid hormone normalization and male reproductive hormone modulation[3][4]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements. Related research: For distinct compound, component, or formulation evidence and safety context, read Gonadorelin Peptide: Benefits, Uses, Side Effects, Dosage, and Research. These links are comparisons only; the compounds and formulations should not be treated as interchangeable.

Source: peptidedosages.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →